NASDAQ : RXST
RxSight, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.05 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 210.05M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 199.65M |
| Enterprise Value | 1.43M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 41.59M |
| Shares Outstanding | 41.59M |
| Shares Change (YoY) | +2.18% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 5.70% |
| Owned by Institutions (%) | 84.53% |
| Float | 33.71M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| Forward PS | 1.26 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.07 |
| Quick Ratio | 3.57 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,936.64 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -17.35% |
| Return on Assets (ROA) | -10.41% |
| Return on Invested Capital (ROIC) | -87.93% |
| Return on Capital Employed (ROCE) | -20.24% |
| Weighted Average Cost of Capital (WACC) | 10.01% |
| Revenue Per Employee | $276,751 |
| Profits Per Employee | -$101,842 |
| Employee Count | 461 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.92 |
Taxes
| Measure | Value |
|---|
| Income Tax | 110,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -44.82% |
| 50-Day Moving Average | 5.37 |
| 200-Day Moving Average | 6.34 |
| Relative Strength Index (RSI) | 45.95 |
| Average Volume (20 Days) | 648,671 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.12M |
| Short Previous Month | 4.09M |
| Short % of Shares Out | 9.90% |
| Short % of Float | 12.22% |
| Short Ratio (days to cover) | 5.26 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 127.58M |
| Gross Profit | 98.88M |
| Operating Income | -55.11M |
| Pretax Income | -46.84M |
| Net Income | -46.95M |
| EBITDA | -51.58M |
| EBIT | -55.11M |
| Loss Per Share | -$1.14 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 208.80M |
| Total Debt | 10.58M |
| Net Cash | 198.22M |
| Net Cash Per Share | $4.77 |
| Equity (Book Value) | 263.34M |
| Book Value Per Share | 6.33 |
| Working Capital | 246.95M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -22.73M |
| Capital Expenditures | -4.43M |
| Depreciation & Amortization | 3.54M |
| Net Borrowing | -24,000 |
| Free Cash Flow | -27.17M |
| FCF Per Share | -$0.65 |
Margins
| Measure | Value |
|---|
| Gross Margin | 77.50% |
| Operating Margin | -43.20% |
| Pretax Margin | -36.71% |
| Profit Margin | -36.80% |
| EBITDA Margin | -40.42% |
| EBIT Margin | -43.20% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.18% |
| Shareholder Yield | -2.18% |
| Earnings Yield | -23.72% |
| FCF Yield | -13.62% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $7.57 |
| Price Target Difference | 57.69% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 7.58% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |